TB Research

Discovery of novel anti-infective agents

Chatterjee AK

Advances in pharmacology (San Diego, Calif.) · 2024-06

Abstract

Academic and other non-profit institutions have a long-term vision to improve human health where commercial interests can be limited for profit organizations. Medicinal chemistry to these diseases with no commercial benefit needs is well suited in the academic environment and this chapter outlines some work conducted at Calibr-Skaggs around antibiotic drug development that has led to initiation of multiple clinical trials over the last decade.

MeSH terms

  • Animals
  • Humans
  • Anti-Infective Agents
  • Anti-Bacterial Agents
  • Drug Discovery